Two important new developments may mean that many more researchers will soon be able to access and analyze data from many more clinical trials.
… a preliminary report from the prestigious Institute of Medicine lends strong support to the open data movement. The IOM report states that investigators should be required to establish a data-sharing plan at the same time the trial is registered. The report includes detailed recommendations for when and how the data should be made available. Among the major recommendations: data underlying a trial analysis should be made available within 6 months after journal publication, and all data should be made available no later than 18 months after the last patient visit in the trial.
… the Yale University Open Data Access (YODA) Project announced that Johnson & Johnson is expanding its plans to share data.